EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long‐Term Post‐Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti‐Aging Compounds

Larissa Traxler, Lukas Karbacher iD, Oliver Borgogno iD, Taylor Ozbun, Kylie Champion iD, Anna Smaling, Lucia Zhou-Yang iD, Joseph R Herdy iD, Lena Böhnke iD, Barbara C Böckle, Fred H Gage iD, Hildegard I D Mack und 2 weitere

Aging Cell · 2026-11 · 25 (11)

DOI: 10.1111/acel.70796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 01.11.2026. Verfasst von Larissa Traxler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Fibroblasts, Cellular Senescence, Aging, Mitosis. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, California Institute for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biological aging drives cellular dysfunction and human disease, yet studying human aging dynamics remains challenging due to limited experimental platforms. Here we show that long‐term post‐mitotic culture of human fibroblasts recapitulates and accelerates features of in vivo aging. Longitudinal paired transcriptomic and epigenetic analyses of four female fibroblast lines revealed that in vitro aging reflects key signatures of in vivo primary fibroblast aging. Direct neuronal conversion of in vitro‐aged fibroblasts preserved biological age, enabling pseudo‐longitudinal modeling of neuronal aging through direct reprogramming. Single‐cell transcriptomics of in vitro‐aging fibroblasts revealed a time‐dependent increase in age‐heterogeneity, consistent with the previously reported age‐associated heterogeneity driven by the variable loss of transcriptional programs in vivo. Using this accelerated aging platform, we evaluated anti‐aging compounds: Metformin broadly attenuated transcriptomic and epigenetic aging, while Rapamycin showed limited efficacy. These findings align with pre‐clinical evidence, providing a platform to evaluate and predict therapeutic anti‐aging compound efficacy at molecular resolution. This system advances our understanding of aging mechanisms and facilitates the development of interventions against age‐related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsCellular SenescenceAgingMitosisHumansFemaleMetforminSirolimusEpigenesis, GeneticTranscriptome

Substanzen

MetforminSirolimus

Autor:innen und Institutionen

  • Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
  • Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California, USA.
  • Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California, USA.
  • Institute for Molecular Biology, University of Innsbruck, Innsbruck, Austria.
  • Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.
  • Department of Biochemistry and Genetics of Aging, Research Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Tyrol, Austria.

ORCID-Profile: Lukas Karbacher, Oliver Borgogno, Kylie Champion, Lucia Zhou-Yang, Joseph R Herdy, Lena Böhnke, Fred H Gage, Michaela Defrancesco, Jerome Mertens

Förderung

  • NIA NIH HHS
  • NIH HHS
  • California Institute for Regenerative Medicine
  • American Federation for Aging Research
  • Live Like Lou Foundation
  • BrightFocus Foundation
  • NINDS NIH HHS
  • Alzheimer's Association

Zitieren

APA

Traxler, L., Karbacher, L., Borgogno, O., Ozbun, T., Champion, K., Smaling, A., Zhou-Yang, L., Herdy, J. R., Böhnke, L., Böckle, B. C., Gage, F. H., Mack, H. I. D., Defrancesco, M., & Mertens, J. (2026). Long‐Term Post‐Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti‐Aging Compounds. Aging Cell, 25(11). https://doi.org/10.1111/acel.70796

Vancouver

Traxler L, Karbacher L, Borgogno O, Ozbun T, Champion K, Smaling A, et al. Long‐Term Post‐Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti‐Aging Compounds. Aging Cell. 2026;25(11). doi:10.1111/acel.70796

BibTeX
@article{Traxler2026,
  author = {Traxler, Larissa and Karbacher, Lukas and Borgogno, Oliver and Ozbun, Taylor and Champion, Kylie and Smaling, Anna and Zhou-Yang, Lucia and Herdy, Joseph R and Böhnke, Lena and Böckle, Barbara C and Gage, Fred H and Mack, Hildegard I D and Defrancesco, Michaela and Mertens, Jerome},
  title = {Long‐Term Post‐Mitotic Culture of Human Fibroblasts Recapitulates and Accelerates Features of In Vivo Aging and Enables Dynamic Testing of Anti‐Aging Compounds},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {11},
  doi = {10.1111/acel.70796}
}
Kostenlos starten →